Medicare Part B Wound Care Billing: Essential Basics

Medicare Part B Wound Care Billing: What Every Practice Needs to Know

Medicare Part B wound care billing is the revenue foundation for most independent wound care practices. Part B covers outpatient and physician-office services, which means every mobile wound care visit, every debridement in a clinic, and every skin substitute application billed to Medicare runs through the Part B framework. Understanding how Part B coverage works — what it pays for, what it limits, and what documentation it demands — is the difference between a sustainable practice and one that hemorrhages revenue to preventable denials.

This guide covers the Part B wound care billing basics: the services Medicare covers, the frequency rules that cap utilization, the documentation that must accompany every claim, and the cost-sharing structure that affects both your collections and your patient relationships.

Covered Wound Care Services Under Part B

Medicare Part B covers wound care services rendered by physicians, nurse practitioners, physician assistants, and clinical nurse specialists when those services are medically necessary and meet the applicable Local Coverage Determination (LCD) criteria. The key service categories include:

Evaluation and Management (E/M) Visits

Every wound care encounter begins with an E/M service. For established patients in a clinic or office setting, codes 99212 through 99215 apply based on medical decision-making complexity. New patient visits use 99202 through 99205. Mobile wound care visits rendered in a patient's home use the home visit codes 99341 through 99345 (new) and 99347 through 99350 (established).

Part B pays the full physician fee schedule amount for E/M services, subject to the 80/20 coinsurance split after the patient meets their annual deductible. The non-facility rate applies when services are rendered outside a hospital outpatient department — which is the case for most independent and mobile wound care practices.

Debridement Services

Selective debridement (97597, 97598) and excisional debridement (11042 through 11047) are among the most commonly billed wound care procedures under Part B. Medicare covers debridement when devitalized, necrotic, or infected tissue is present and removal is clinically necessary to promote healing.

The distinction between selective and excisional debridement matters for reimbursement. Excisional debridement codes pay significantly more — CPT 11042 reimburses approximately $120 non-facility versus $82 for 97597 — but require documentation of surgical technique, instrument use, and tissue depth reaching subcutaneous tissue or deeper.

Skin Substitute Applications

Skin substitute grafts billed under Q codes (Q4101 through Q4271) represent the highest-revenue wound care service under Part B. CMS reimburses skin substitutes at $127.14 per square centimeter (2026 flat rate) for qualifying products, making proper billing essential to practice economics.

Part B covers skin substitutes when the wound meets LCD criteria: typically a chronic wound that has failed at least 30 days of conservative treatment, with documented wound measurements, tissue type percentages, and clinical rationale for application. Each product has a specific Q code, and billing the wrong code or the wrong unit count is a common denial trigger.

Negative Pressure Wound Therapy (NPWT)

NPWT — both the application (CPT 97605, 97606) and ongoing management — is covered under Part B when the wound meets size and depth criteria. Medicare requires documentation that the wound has sufficient depth and exudate to justify NPWT, and that the patient's vascular status supports healing.

Medicare Part B Frequency Limitations

Part B does not impose blanket visit limits, but your MAC's LCD effectively creates frequency guardrails through medical necessity criteria. Here's how those limits operate in practice:

Debridement frequency — Most MACs allow selective debridement up to four times per calendar month without additional documentation. A fifth or subsequent debridement in the same month requires the KX modifier and supporting clinical justification explaining why continued debridement is medically necessary.

Skin substitute application frequency — LCDs typically limit skin substitute applications based on wound response. If the wound shows less than a defined percentage of area reduction over a specified number of applications, continued treatment may be denied as not medically necessary. The specific thresholds vary by MAC jurisdiction — consult your LCD compliance requirements for jurisdiction-specific limits.

E/M visit frequency — No hard frequency cap exists for E/M services, but Medicare's medical review contractors flag outlier billing patterns. If your practice consistently bills 99215 on every visit or sees patients three times per week without documented clinical rationale, expect an audit.

Part B Documentation Requirements

Medicare Part B wound care claims require documentation that supports both the medical necessity of the service and the specific coding billed. The documentation must be present in the medical record at the time of service — not added retroactively.

Minimum Documentation Elements Per Visit

Every wound care visit note must include:

Wound measurements — Length, width, and depth in centimeters. Estimated measurements are not acceptable. Use a disposable ruler or validated measurement tool.
Wound location — Anatomical site using standard terminology. "Left leg" is insufficient. "Left lateral malleolus" is correct.
Tissue type and percentages — Granulation, slough, eschar, epithelial tissue, and necrotic tissue with estimated percentages.
Wound bed description — Color, moisture level, odor, exudate type and amount.
Periwound skin assessment — Condition of skin surrounding the wound including maceration, erythema, induration, and temperature.
Vascular status — For all lower extremity wounds, documented pedal pulses or ABI results. Missing vascular assessments are a top-five LCD denial trigger.
Treatment rendered — Specific procedure performed, instruments used, technique description, and clinical rationale.
Plan of care — Next steps, follow-up timeline, and any changes to the treatment plan with rationale.

LCD-Specific Documentation

Beyond these baseline elements, your MAC's LCD adds requirements that vary by jurisdiction. Some LCDs require documented evidence of offloading compliance for diabetic foot ulcers. Others require compression therapy documentation for venous leg ulcers. Failing to address these LCD-specific elements — even when your clinical documentation is otherwise thorough — results in denial. See the full breakdown in our CPT code reference for 2026.

Beneficiary Cost Sharing Under Part B

Understanding Part B cost sharing matters for two reasons: it affects your collections workflow, and it determines what your patients owe out of pocket.

The 80/20 Split

After the patient meets their annual Part B deductible ($257 in 2026), Medicare pays 80% of the Medicare-approved amount. The patient is responsible for the remaining 20% coinsurance. This coinsurance applies to every covered service — E/M visits, debridements, skin substitutes, NPWT, and all other Part B services.

For a skin substitute application billing $1,500, the patient's coinsurance responsibility is $300. For practices that don't collect coinsurance consistently, this adds up to significant revenue leakage over the course of a year.

Medigap and Supplemental Insurance

Most Medicare beneficiaries carry a Medigap (Medicare Supplement) policy or are enrolled in a Medicare Advantage plan that covers the 20% coinsurance. When a patient has Medigap, your practice bills the supplement directly for the coinsurance amount after Medicare processes the primary claim. The crossover claim typically processes automatically if you're enrolled with the Medigap carrier.

For patients without supplemental coverage, establish a clear financial policy and communicate the coinsurance obligation before treatment begins. Wound care treatment plans often span weeks or months, and accumulated coinsurance can create collection challenges.

Dual-Eligible Patients

Patients eligible for both Medicare and Medicaid have their coinsurance covered by Medicaid. Bill Medicare as primary, then bill Medicaid for the coinsurance and deductible. Dual-eligible patients should have zero out-of-pocket cost for covered wound care services. Learn more about payer sequencing in our Medicare fee schedule guide.

Common Part B Billing Mistakes

The most frequent Part B wound care billing errors are not complex. They're structural — the same mistakes repeated across practices because billing workflows don't enforce the basics:

Missing KX modifier — Failing to append the KX modifier when required by the LCD. This is an automatic denial at most MACs.
Incorrect place of service — Billing a home visit with office place-of-service code (11) instead of home (12). Reimbursement rates differ, and the wrong POS triggers review.
Unbundled services — Billing an E/M and debridement separately when the debridement is integral to the E/M service. Medicare expects modifier 25 on the E/M when billed with a minor procedure.
Missing vascular assessment — For lower extremity wounds, absent ABI or pedal pulse documentation is the single most common LCD-based denial.
Skin substitute unit errors — Billing the wrong number of square centimeter units or using the incorrect Q code for the product applied. One unit equals one square centimeter, and rounding rules apply.

Key Takeaways

Medicare Part B covers wound care E/M visits, debridements, skin substitutes at $127.14/sq cm, and NPWT — but only when LCD medical necessity criteria are met and documentation is complete at the time of service.
Frequency limits are LCD-driven, not blanket caps — your MAC's LCD defines how many debridements, applications, and visits are covered without additional justification, and the KX modifier signals you've met the threshold for continued treatment.
Every visit note must include wound measurements, tissue types, vascular status, and a treatment plan — missing any single element can trigger a denial regardless of clinical appropriateness.
Beneficiary cost sharing follows the 80/20 split after the annual deductible — practices that don't collect coinsurance consistently or verify Medigap coverage leave significant revenue uncollected.
The five most common Part B errors are structural, not clinical — missing KX modifiers, wrong place of service, unbundled codes, absent vascular assessments, and skin substitute unit miscounts account for the majority of preventable denials.